Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cancer is caused by complex interactions between genes, environment and lifestyles. Biobanks of well-annotated human tissues are an important resource for studying the underlying mechanisms of cancer. Although such biobanks exist, their integration to form larger biobanks is now required to provide the diversity of samples that are needed to study the complexity and heterogeneity of cancer. Clear guidelines and policies are also required to address the challenges of integrating individual institutional or national biobanks and build public trust. This Science and Society article highlights some of the main practical and ethical issues that are undergoing discussion in the integration of tissue biobanks for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Misinterpretation is a concern when data are assessed without assistance, e.g. from a trained clinician, carer or data scientist (Watson et al. 2010).”
From Ethics of the health-related internet of things: a narrative review (2017) · cites this paper as Watson et al. 2010
Citations
Cites
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen, M. H., Williams, G., Johnson, J. R., Duan, J. Z., Gobburu, J. V. S., Rahman, A., Benson, K. A., Leighton, J. K., Kim, S. K., Wood, R., et al. (2002) · PubMed · Cited by 462
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429 · cited 1×
“, the use of monoclonal antibodies that target the epidermal growth factor receptor (EGFR) in patients with EGFR-expressing metastatic colon cance”
Should donors be allowed to give broad consent to future biobank research?
Hansson, M. G., Dillner, J., Bartram, C. R., Carlson, J. A., & Helgesson, G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70618-0 · Cited by 382
Burton, P. R., Hansell, A. L., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 258
Solidarity and equity: new ethical frameworks for genetic databases
Chadwick, R., & Berg, K. (2001) · Nature Reviews Genetics · doi:10.1038/35066094 · Cited by 254
Elger, B. S., & Caplan, A. L. (2006) · EMBO reports · doi:10.1038/sj.embor.7400740 · Cited by 196
Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development
Tan, D. S. W., Thomas, G. V., Garrett, M. D., Banerji, U., de Bono, J. S., Kaye, S. B., & Workman, P. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e3181bd0445 · Cited by 171
End points in cancer clinical trials and the drug approval process.
Schilsky, R. L. (2002) · PubMed · Cited by 170
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
Taube, S. E., Clark, G. M., Dancey, J. E., McShane, L. M., Sigman, C. C., & Gutman, S. I. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp334 · Cited by 158
Rules for Research on Human Genetic Variation — Lessons from Iceland
Annas, G. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422412 · Cited by 115 · cited 1×
“To what extent can such consent about the unknown future be accurately described as informed consent”
Cited by
The ethics of big data: current and foreseeable issues in biomedical contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-015-9652-2 · Cited by 714
“For instance, providing data subjects with unrestricted access to raw data may be harmful in the sense that it is practically useless or open to misinterpretation without the presence of a trained clinician or analyst to explain its significance (Watson et al. 2010).”
BackgroundCancer biomarker discovery and validation.
Goossens, N., Nakagawa, S., Sun, X., & Hoshida, Y. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.06.04 · Cited by 503
“However, in part due to the complex and heterogeneous nature of cancer, it has become increasingly recognized, that there is a need for larger integrated biobanks (32,33) which require careful development and adherence to published biobanking guidelines (34).”
BackgroundBiobanking: the foundation of personalized medicine
Hewitt, R. E. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834161b8 · Cited by 288
Ethics of the health-related internet of things: a narrative review
Mittelstadt, B. (2017) · Ethics and Information Technology · doi:10.1007/s10676-017-9426-4 · Cited by 154
The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Law, Governance and Technology Series · doi:10.1007/978-3-319-33525-4_19 · Cited by 159
Ethical aspects of human biobanks: a systematic review
Mršić, D. B., Polašek, O., Marušić, A., Kolčić, I., Zemunik, T., Perica, V. B., Jerončić, A., Boban, M., Campbell, H., & Rudan, I. (2011) · Croatian Medical Journal · doi:10.3325/cmj.2011.52.262 · Cited by 164
Biopsies: next-generation biospecimens for tailoring therapy
Basik, M., Aguilar‐Mahecha, A., Rousseau, C., Diaz, Z., Tejpar, S., Spatz, A., Greenwood, C. M. T., & Batist, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.101 · Cited by 126
An NCI Perspective on Creating Sustainable Biospecimen Resources
Vaught, J., Rogers, J., Myers, K., Lim, M. D., Lockhart, N. C., Moore, H. A., Sawyer, S. J., Furman, J. L., & Compton, C. C. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr006 · Cited by 106
Critchley, C. R., Nicol, D., & Otlowski, M. F. A. (2015) · Public Health Genomics · doi:10.1159/000375441 · Cited by 105
Tan, H. T., Lee, Y. H., & Chung, M. C. M. (2012) · Mass Spectrometry Reviews · doi:10.1002/mas.20356 · Cited by 91
Bao, W.-G., Zhang, X., Zhang, J., Zhou, W., Bi, T., Wang, J., Yan, W., & Lin, A. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2440-1 · Cited by 71
Sampling Populations of Humans Across the World: ELSI Issues
Knoppers, B. M., Zawati, M. H., & Kirby, E. S. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163834 · Cited by 67
Massett, H. A., Atkinson, N. L., Weber, D., Myles, R., Ryan, C., Grady, M., & Compton, C. C. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr007 · Cited by 64
“biospecimens scientists use (5), and progress in the fight against”
BackgroundDesigning the Health-related Internet of Things: Ethical Principles and Guidelines
Mittelstadt, B. (2017) · Information · doi:10.3390/info8030077 · Cited by 62
“Misinterpretation is a concern when data are assessed without assistance from a trained clinician, service provider or caregiver [106].”
Quality matters: International standards for biobanking
Dagher, G. (2022) · Cell Proliferation · doi:10.1111/cpr.13282 · Cited by 51
“They are important to personalized medicine and translational research, and thus must be collected and processed following standards that safeguard quality and annotated with the appropriate patient-related and biospecimen-specific information.(6) High-quality well-annotated biospecimens for research are currently in…”
BackgroundWang, Y.-G., Zheng, H., Chen, J., Zhong, X., Wang, Y., Wang, Z., & Wang, Y. (2015) · Biopreservation and Biobanking · doi:10.1089/bio.2015.0029 · Cited by 47
Identifying public expectations of genetic biobanks
Critchley, C. R., Nicol, D., & McWhirter, R. (2016) · Public Understanding of Science · doi:10.1177/0963662515623925 · Cited by 48
Sun, H., Sun, R., Hao, M., Wang, Y., Zhang, X., Liu, Y., & Cong, X. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4327-9 · Cited by 36
“Multiple factors may influence their quality.(4,5) An example is the the ex vivo ischemia time, which is defined as the interval between surgical removal of a tissue and snap”
BackgroundLewis, C. E., McQuaid, S., Hamilton, P. W., Salto‐Tellez, M., McArt, D. G., & James, J. A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.08.009 · Cited by 35
Charon: A Secure Cloud-of-Clouds System for Storing and Sharing Big Data
Mendes, R., Oliveira, T., Cogo, V. V., Neves, N., & Bessani, A. (2019) · IEEE Transactions on Cloud Computing · doi:10.1109/tcc.2019.2916856 · Cited by 43
“For example, 20– 50k samples are required to study the interactions between genes, environment, and lifestyle that enable (or inhibit) a complex disease [12].”
BackgroundAn oral cancer biobank initiative: a platform for multidisciplinary research in a developing country
Zain, R. B., Vimmitra, A., Ghani, W. M. N., Razak, I. A., Jallaludin, R. L. R., Ismail, S. M., Sallam, A. A., Bustam, A. Z., Rahman, Z. A. A., Hussien, A., et al. (2012) · Cell and Tissue Banking · doi:10.1007/s10561-012-9298-0 · Cited by 32
“The MOCDTBS also promotes sharing among researchers and the development of a multidisciplinary research team.”
BackgroundImproving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network
Simon, M. A., de la Riva, E. E., Bergan, R. C., Norbeck, C., McKoy, J. M., Kulesza, P., Dong, X., Schink, J. C., & Fleisher, L. G. (2014) · Journal of Cancer Education · doi:10.1007/s13187-014-0617-y · Cited by 31
“Unfortunately, limited diversity in research participation reduces output and yields applications that do not speak to the complexity and heterogeneity of cancer and its impact on minority populations [1].”
Ethical aspects of aging research
Seppet, E. K., Pääsuke, M., Conte, M., Capri, M., & Franceschi, C. (2011) · Biogerontology · doi:10.1007/s10522-011-9340-9 · Cited by 28
“institutions (Hawkins 2010; Watson et al. 2010).”
Shiwa, Y., Hachiya, T., Furukawa, R., Ohmomo, H., Ono, K., Kudo, H., Hata, J., Hozawa, A., Iwasaki, M., Matsuda, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147519 · Cited by 28
“The integration of existing biobanks can offer an adequate number of samples [10]; however, differences in DNA collection protocols among biobanks with respect to anticoagulants, time until centrifugation after blood collection, and the blood fraction used for DNA extraction (whole blood or buffy coat) may be addition…”
BackgroundAccess to Biobanks: Harmonization Across Biobank Initiatives
Verlinden, M., Nys, H., Ectors, N., & Huys, I. (2014) · Biopreservation and Biobanking · doi:10.1089/bio.2014.0034 · Cited by 20
Myles, R., Massett, H. A., Comey, G., Atkinson, N., Allsop, D., & Compton, C. C. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr008 · Cited by 19
Wu, X., Zheng, H., Dou, Z., Chen, F., Deng, J., Chen, X., Xu, S., Gao, G., Li, M., Wang, Z., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa090 · Cited by 20
The Significance of Biobanking in the Sustainability of Biomedical Research: A Review
Zohouri, M., & Ghaderi, A. A. (2020) · Iranian Biomedical Journal · doi:10.29252/ibj.24.4.206 · Cited by 24
“On the other hand, the quality of biospecimens affects the quality of biomedical research so that biospecimens of unknown or poor quality can invalidate research findings [7,8] .”
BackgroundResearch ethics in the post‐genomic era
Vähäkangas, K. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21804 · Cited by 21
“However, various authors and organizations have described the difficulties in getting individual informed consent for long-term big biobank projects, especially for future, undefined studies with no consensus about best practices [Reymond et al., 2002; V€ah€akangas, 2004; Cambon-Thomsen, 2004; Helgesson et al., 2007;…”
BackgroundSustained Interaction: the New Normal for Stem Cell Repositories?
Isasi, R. M., Knoppers, B. M., & Lomax, G. P. (2011) · Regenerative Medicine · doi:10.2217/rme.11.93 · Cited by 14
Protecting Genetic Privacy in Biobanking through Data Protection Law
Hallinan, D. (2021) · doi:10.1093/oso/9780192896476.001.0001 · Cited by 22
The Needle in the Haystack: International Consortia and the Return of Individual Research Results
Wallace, S. E. (2011) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2011.00630.x · Cited by 13
Biorepositories for cancer research in developing countries
Ray, S., Moiyadi, A. V., & Srivastava, S. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.119 · Cited by 13
Evolution of biobanks and ethical governance for the emerging applications in biomedical research
Chandrashekar, C., Shetty, S. S., & Radhakrishnan, R. A. (2022) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_478_22 · Cited by 12
“Journal of Oral and Maxillofacial Pathology | Volume 26 | Issue 4 | October-December 2022 435 storage, or distribution of biological samples and related data.[21] The premise for running a biobank successfully is to follow best practises that could increase the samples’ long‐term usefulness and to uphold the fundament…”
BackgroundRollison, D. E. M., Gonzalez, B. D., Turner, K. L., Jim, H., Zhao, Y., Amorrortu, R. P., Howard, R., Ghia, K. M., Ngo, B., Reisman, P., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6459 · Cited by 11
Precision Radiotherapy and Radiation Risk Assessment: How Do We Overcome Radiogenomic Diversity?
Fukunaga, H., Yokoya, A., Taki, Y., Butterworth, K. T., & Prise, K. M. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.247.223 · Cited by 11
“In recent years, the number of biobanks has dramatically increased in support of industry and academic genomic research in disease prevention, prediction, diagnosis and treatment (Watson et al. 2010; Gaskell and Gottweis 2011; De Souza and Greenspan 2013; Olson et al. 2014; Chalmers et al. 2016).”
BackgroundEnterprise Support Hierarchical Model with Secure Data Protocol
Vinay Simha Reddy, T., Parvathi, S., Sarada, C., Mohmmed, K. H., Murthy, A. S. D., & Saikumar, K. (2023) · International Conference on Smart Generation Computing, Communication and Networking (SMART GENCON) · doi:10.1109/smartgencon60755.2023.10442282 · Cited by 8
“Your expense per work, thing, or item goes down [13].”
BackgroundEstablishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital
Kong, F., Zhang, W., Qiao, L., Li, Q., Li, H., Cao, J., He, W., Dong, C., He, Y., He, L., et al. (2018) · PeerJ · doi:10.7717/peerj.4450 · Cited by 8
Zheng, X., Zhang, S.-D., Zhang, P., Li, X., Hu, Y., Tian, T., Zhu, L. F., Wang, R., & Jia, W. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6697-x · Cited by 7
Zheng, X., Zhou, T., Li, X., Zhang, P., & Jia, W. (2022) · Biopreservation and Biobanking · doi:10.1089/bio.2021.0124 · Cited by 6
Lohrisch, C. A., Francl, M. I., Sun, S. B., Villa, D. R., & Gelmon, K. A. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4586-9 · Cited by 6
Biobanking in oncology and radiology
Roumiantsev, P. O., & Mudunov, A. M. (2018) · Endocrine Surgery · doi:10.14341/serg9555 · Cited by 6
Leveraging Informatics, Mobile Health Technologies and Biobanks to Treat Each Patient Right
Hirsch, B. R., & Abernethy, A. P. (2012) · Personalized Medicine · doi:10.2217/pme.12.102 · Cited by 6
Trillsch, F., Reichenbach, J., Czogalla, B., Kraus, F. B. T., Burges, A., Mahner, S., & Kessler, M. (2024) · Journal of Visualized Experiments · doi:10.3791/66467 · Cited by 7
Nwankwo, I., Hänold, S., & Forgo, N. P. (2012) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2012.6399764 · Cited by 5
“There is an interest to reuse data because it may be inefficient and contrary to the public good to collect new similar data at public expense, especially, in the field of genetic studies that require retrospective data [17], [18].”
BackgroundTranslational Research in Oncology
Qazi, A. S., Akbar, S., Saeed, R. F., & Bhatti, M. Z. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_11 · Cited by 5
Pak, M. G., & Roh, M. S. (2020) · Kosin Medical Journal · doi:10.7180/kmj.2020.35.1.26 · Cited by 5
Guérin, M., Qian, C., Zhong, Q., Cui, Q., Guo, Y., Bei, J., Shao, J., Zhu, X., Huang, W., Wu, J., et al. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4398-4 · Cited by 4
Evolution of Ideas with in the Business Strategy from Historical Perspective
Shabbir, M. S. (2016) · Arabian Journal of Business and Management Review · doi:10.4172/2223-5833.1000236 · Cited by 3
“The study of historical figure and other personal materials is a common practice for nowadays of the researchers [13].”
BackgroundJonnagaddala, J., Jue, T. R., RAY, P. K., & Talaei‐Khoei, A. (2014) · The International Technology Management Review · doi:10.2991/itmr.2014.4.2.1 · Cited by 3
Chang, Z., Hu, H., Pan, X., Liu, C., Liu, K., Zhang, Y., Xu, S., Cheng, J., Zhang, Q., Wan, Q., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47915-x · Cited by 3
Ethical aspects of human tissue research : views of the stakeholders
Halkoaho, A. (2012) · UEF eRepo (University of Eastern Finland) · Cited by 7
Issues of banking breast cancer cells to generate mammospheres
Veneziani, B. M., & Placido, S. D. (2012) · Cell and Tissue Banking · doi:10.1007/s10561-012-9320-6 · Cited by 2
“A breast cancer biobank is a collection of biological specimens, and corresponding clinical data from patients with breast cancer (Watson et al. 2010).”
Background김수경, Kim, S., & 이경화 (2018) · Korean Journal of Medical Ethics · doi:10.35301/ksme.2018.21.4.34 · Cited by 2
Sookyung, K. I. M., Lee, K., & Sanghee, K. I. M. (2018) · Korean Journal of Medical Ethics · doi:10.35301/ksme.2018.21.4.330 · Cited by 2
Zheng, X., & Jia, W. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6723-z · Cited by 2
Enabling the Efficient, Dependable Cloud-Based Storage of Human Genomes
Cogo, V. V., & Bessani, A. (2019) · IEEE Symposium on Reliable Distributed Systems Workshops (SRDSW) · doi:10.1109/srdsw49218.2019.00011 · Cited by 2
“One million human genomes is an interesting example of the scale biobanks will face since they already manage similar numbers of physical samples [7].”
BackgroundEthics of the Health-Related Internet of Things: A Narrative ReviewPreprint
Mittelstadt, B. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.2932221 · Cited by 2
La recherche biomédicale à l’ère des tumorothèques: Point de vue des patients atteints de cancer
Mancini, J., Chabannon, C., Vey, N., Billard, L.-M., Pellegrini, I., & Julian‐Reynier, C. (2012) · médecine/sciences · doi:10.1051/medsci/2012281s108 · Cited by 1
Devereux, L. M., Thorne, H., & Fox, S. B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6643-1_2 · Cited by 1
“Fortunately there are a few good examples of regional and inter- and intra-country networks that have managed to resolves many of these problems and established medium to large scale facilities receiving a combination of government, not for profit and foundation funding [6, 10, 14, 38, 44, 45] to support their combine…”
BackgroundScientific Method, Human Research Ethics, and Biosafety/Biosecurity
de Winter, J., & Dodou, D. (2017) · SpringerBriefs in applied sciences and technology · doi:10.1007/978-3-319-56964-2_1 · Cited by 1
Biobanken als wissenschaftliche Ressourcen
Nöthlings, U., & Kohlenberg, A. (2012) · Der Gynäkologe · doi:10.1007/s00129-011-2859-7
Standard based Deposit Guideline for Distribution of Human Biological Materials in Cancer Patients
Seo, H. J., Kim, H. H., Im, J. S., & Kim, J. H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.14.5545
DISCOVERY AND VALIDATION OF PROTEIN BIOMARKERS FOR LUNG CANCER
Petris, L. D. (2010) · Figshare · Cited by 2
P3G: Towards an International Policy Platform for Population Genomics
Rahimzadeh, V. N., Tassé, A. M., Ouellette, S., Knoppers, B. M., & Fortier, I. (2017) · Springer eBooks · doi:10.1007/978-3-319-55120-3_9
Testing the GDPR in Relation to Biobanking
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0007
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0010
The Protection of Genetic Privacy in Biobanking at International Level
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0005
Testing the GDPR in Relation to Biobanking
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0008
Genetic Data, Genome Understanding, and Socially Relevant Information
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0002
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0009
Genetic Privacy and Other Interests in Biobanking: Conflict and Confluence
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0004
The Context and State of the Art in European Biobanking
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0003
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0006
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0001
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.003.0011
Implementation of Ethical and Legal Considerations in a Biobanking Network
Gramatiuk, S. M., Alekseenko, M., Macheiner, T., Mitchell, C., & Sargsyan, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-87637-1_8
Rhodes, C. (2013) · Edward Elgar Publishing eBooks · doi:10.4337/9781781007006.00017
Radhakrishnan, R. A. (2022) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_385_22
“Harmonisation of policies, a key role of the IRB and IEC, as well as other concerns such as patient access to information and withdrawals of samples and data, are necessary for the biobanks to operate effectively and for the efficient use of resources.[10]”
BackgroundTechniques to Share and Store Large Data in Used System to Reduce Network Traffic and Cost
Kamble, P. S., & Sawant, N. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-34648-4_22
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.002.0005
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.002.0003
Table of Cases and Legislation
Hallinan, D. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780192896476.002.0006
Share and Store Data in Used System to Reduce Traffic
Kamble, P. S., Sawant, N. M., & Bhosale, D. P. (2026) · Lecture notes in electrical engineering · doi:10.1007/978-981-95-5831-5_6
Johann, D. J., Hicks, J. B., Albain, K. S., Barlow, W. E., Godwin, A. K., Hayes, D. F., Hutchins, L. F., Killian, J. K., Peterson, E. A., Piña‐Oviedo, S., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-26-00152
Metadata
- Authors
- Watson, R. W. G., Kay, E. W., & Smith, D.
- Affiliations
- University College Dublin (IE)
- Royal College of Surgeons in Ireland (IE)
- Corresponding author
- Watson, R. William G.
- Venue
- Nature Reviews Cancer
- Published
- 2010-08-12
- Volume
- 10
- Issue
- 9
- Pages
- 646-651
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2030361273
- Cited by
- 88
- References
- 32
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 15 · 2020: 4 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 11
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- cancer research, research ethics, public trust, biobank governance, sample diversity, tumor heterogeneity
- MeSH terms
- Animals, Humans, Neoplasms, Guidelines as Topic, Biological Specimen Banks, Bioethical Issues, Ethics, Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.